HIV-1 capsid and viral DNA integration.
Richa DwivediPrem PrakashBajarang Vasant KumbharMuthukumar BalasubramaniamChandravanu DashPublished in: mBio (2023)
HIV-1 capsid protein (CA)-independently or by recruiting host factors-mediates several key steps of virus replication in the cytoplasm and nucleus of the target cell. Research in the recent years have established that CA is multifunctional and genetically fragile of all the HIV-1 proteins. Accordingly, CA has emerged as a validated and high priority therapeutic target, and the first CA-targeting antiviral drug was recently approved for treating multi-drug resistant HIV-1 infection. However, development of next generation CA inhibitors depends on a better understanding of CA's known roles, as well as probing of CA's novel roles, in HIV-1 replication. In this timely review, we present an updated overview of the current state of our understanding of CA's multifunctional role in HIV-1 replication-with a special emphasis on CA's newfound post-nuclear roles, highlight the pressing knowledge gaps, and discuss directions for future research.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- drug resistant
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- protein kinase
- multidrug resistant
- emergency department
- drug delivery
- sars cov
- cancer therapy
- stem cells
- south africa
- mesenchymal stem cells
- cystic fibrosis
- single molecule
- circulating tumor
- amino acid